دورية أكاديمية

Neuroprotective effect of gallic acid in mice with rotenone-induced neurodegeneration.

التفاصيل البيبلوغرافية
العنوان: Neuroprotective effect of gallic acid in mice with rotenone-induced neurodegeneration.
المؤلفون: Thong-Asa W; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand., Wassana C; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand., Sukkasem K; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand., Innoi P; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand., Dechakul M; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand., Timda P; Animal Toxicology and Physiology Specialty Research Unit (ATPSRU), Department of Zoology, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Jatujak, Bangkok 10900, Thailand.
المصدر: Experimental animals [Exp Anim] 2024 Jul 09; Vol. 73 (3), pp. 259-269. Date of Electronic Publication: 2024 Feb 01.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Japanese Association for Laboratory Animal Science Country of Publication: Japan NLM ID: 9604830 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1881-7122 (Electronic) Linking ISSN: 00075124 NLM ISO Abbreviation: Exp Anim Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Tokyo : Japanese Association for Laboratory Animal Science
مواضيع طبية MeSH: Rotenone* , Gallic Acid*/pharmacology , Gallic Acid*/administration & dosage , Neuroprotective Agents*/pharmacology , Neuroprotective Agents*/administration & dosage, Animals ; Male ; Mice, Inbred ICR ; Corpus Striatum/metabolism ; Corpus Striatum/drug effects ; Mice ; Oxidative Stress/drug effects ; Neurodegenerative Diseases/chemically induced ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/prevention & control ; Lipid Peroxidation/drug effects ; Tyrosine 3-Monooxygenase/metabolism
مستخلص: We investigated the effect of gallic acid (Gal) against neurodegenerative pathophysiology relevant to Parkinsion's disease (PD) in mice with rotenone-induced toxicity. Forty male institute of cancer research (ICR) mice were randomly divided into four groups: sham-veh, PD-veh (received subcutaneous injection with 2.5 mg/kg/48 h of rotenone); PD-Gal50; and PD-Gal100 (the latter two groups received subcutaneous injection with 2.5 mg/kg/48 h of rotenone and oral gavage with gallic acid 50 and 100 mg/kg/48 h, respectively). All treatments continued for 5 weeks with motor ability assessments once per week using hanging and rotarod tests. Brain tissue evaluation of oxidative status, together with striatal and substantia nigra par compacta (SNc) histological and immunohistological assessments were performed. The results indicate that rotenone significantly induced muscle weakness and motor coordination deficit from the first week of rotenone injection, and a significant increase in neuronal degeneration was presented in both the striatum and SNc. Decreased tyrosine hydroxylase and increment of glia fibrillary acidic protein expression in SNc were depicted. The deteriorating effects of rotenone were ameliorated by gallic acid treatment, especially 100 mg/kg dose. Rotenone did not induce a significant change of lipid peroxidation indicated, but gallic acid exhibited a significant inhibitory effect on the lipid peroxidation increment. Rotenone showed a significant reduction of superoxide dismutase activity, and neither 50 nor 100 mg/kg of gallic acid could alleviate this enzyme activity. In conclusion, gallic acid ameliorated motor deficits and preserving SNc neurons which led to maintaining of the dopaminergic source, including a nurturing effect on supporting astrocytes in mice with rotenone-induced neurodegeneration.
References: Acta Neuropathol. 2010 Jan;119(1):7-35. (PMID: 20012068)
Metab Brain Dis. 2023 Jan;38(1):373-382. (PMID: 36308586)
Metab Brain Dis. 2022 Jun;37(5):1465-1476. (PMID: 35353275)
Front Neurol. 2019 Mar 19;10:218. (PMID: 30941085)
Avicenna J Phytomed. 2017 Sep-Oct;7(5):389-400. (PMID: 29062800)
Pharmacol Biochem Behav. 2013 Mar;104:132-7. (PMID: 23313549)
J Neurosci. 2003 Nov 26;23(34):10756-64. (PMID: 14645467)
J Biol Chem. 2020 Nov 27;295(48):16251-16266. (PMID: 32913125)
Int J Epidemiol. 2018 Feb 1;47(1):299-310. (PMID: 29136149)
Int J Environ Res Public Health. 2019 Oct 10;16(20):. (PMID: 31658620)
Avicenna J Phytomed. 2018 May-Jun;8(3):210-226. (PMID: 29881707)
J Biol Chem. 1951 Nov;193(1):265-75. (PMID: 14907713)
Acta Pharmacol Sin. 2017 Oct;38(10):1317-1328. (PMID: 28649132)
Front Cell Neurosci. 2021 Nov 17;15:755955. (PMID: 34867201)
Brain Res Bull. 2015 Apr;113:34-40. (PMID: 25732239)
Chin Med. 2023 Mar 15;18(1):27. (PMID: 36918923)
Neurochem Res. 2018 Jun;43(6):1150-1160. (PMID: 29671234)
P T. 2015 Aug;40(8):504-32. (PMID: 26236139)
Neurotox Res. 2017 Aug;32(2):172-174. (PMID: 28455778)
Handb Clin Neurol. 2019;161:167-186. (PMID: 31307598)
Metab Brain Dis. 2021 Dec;36(8):2567-2577. (PMID: 34436745)
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a009282. (PMID: 22675667)
Int J Mol Sci. 2020 May 04;21(9):. (PMID: 32375371)
Mol Neurobiol. 2019 Apr;56(4):2728-2740. (PMID: 30056575)
Iran J Basic Med Sci. 2019 Mar;22(3):225-237. (PMID: 31156781)
Environ Health Perspect. 2011 Jun;119(6):A259. (PMID: 21628118)
Ann Neurosci. 2018 May;24(4):233-242. (PMID: 29849447)
Neuron. 2003 Sep 11;39(6):889-909. (PMID: 12971891)
Iran J Basic Med Sci. 2018 Dec;21(12):1232-1237. (PMID: 30627366)
Metab Brain Dis. 2018 Jun;33(3):765-773. (PMID: 29344828)
Neurobiol Dis. 2022 Jun 1;167:105685. (PMID: 35257879)
PLoS One. 2015 Nov 05;10(11):e0142140. (PMID: 26540301)
Food Chem. 2013 Jun 1;138(2-3):1028-33. (PMID: 23411210)
فهرسة مساهمة: Keywords: Parkinson’s disease; gallic acid; rotenone; striatum; substantia nigra
المشرفين على المادة: 03L9OT429T (Rotenone)
632XD903SP (Gallic Acid)
0 (Neuroprotective Agents)
EC 1.14.16.2 (Tyrosine 3-Monooxygenase)
تواريخ الأحداث: Date Created: 20240131 Date Completed: 20240710 Latest Revision: 20240719
رمز التحديث: 20240719
مُعرف محوري في PubMed: PMC11254496
DOI: 10.1538/expanim.23-0165
PMID: 38296489
قاعدة البيانات: MEDLINE
الوصف
تدمد:1881-7122
DOI:10.1538/expanim.23-0165